CrowdStrike Holdings, Inc.

NasdaqGS:CRWD Stock Report

Mkt Cap: US$26.6b

We’ve recently updated our valuation analysis.

CrowdStrike Holdings Valuation

Is CRWD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CRWD?

Other financial metrics that can be useful for relative valuation.

CRWD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue12.3x
Enterprise Value/EBITDA-318.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CRWD's PS Ratio compare to its peers?

The above table shows the PS ratio for CRWD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average13.8x
ZS Zscaler
16x22.6%US$19.5b
FTNT Fortinet
10.1x16.2%US$41.4b
GTLB GitLab
20.6x30.0%US$7.8b
PANW Palo Alto Networks
8.3x17.0%US$48.3b
CRWD CrowdStrike Holdings
13.1x21.9%US$26.6b

Price-To-Sales vs Peers: CRWD is good value based on its Price-To-Sales Ratio (13.1x) compared to the peer average (13.8x).


Price to Earnings Ratio vs Industry

How does CRWD's PE Ratio compare vs other companies in the US Software Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.0%
n/an/an/a

Price-To-Sales vs Industry: CRWD is expensive based on its Price-To-Sales Ratio (13.1x) compared to the US Software industry average (4.8x)


Price to Sales Ratio vs Fair Ratio

What is CRWD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CRWD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio13.1x
Fair PS Ratio10.1x

Price-To-Sales vs Fair Ratio: CRWD is expensive based on its Price-To-Sales Ratio (13.1x) compared to the estimated Fair Price-To-Sales Ratio (10.1x).


Share Price vs Fair Value

What is the Fair Price of CRWD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CRWD ($113.56) is trading below our estimate of fair value ($179.25)

Significantly Below Fair Value: CRWD is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CRWD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$113.56
US$162.98
+43.5%
20.2%US$270.00US$110.00n/a42
Jan ’24US$105.29
US$181.21
+72.1%
24.8%US$385.00US$120.00n/a38
Dec ’23US$124.07
US$184.54
+48.7%
24.1%US$385.00US$120.00n/a37
Nov ’23US$160.53
US$238.26
+48.4%
13.0%US$385.00US$193.00n/a37
Oct ’23US$164.81
US$237.91
+44.4%
13.6%US$385.00US$193.00n/a34
Sep ’23US$172.97
US$239.37
+38.4%
14.0%US$385.00US$188.00n/a30
Aug ’23US$183.30
US$232.57
+26.9%
15.2%US$385.00US$188.00n/a30
Jul ’23US$179.25
US$232.97
+30.0%
15.5%US$385.00US$188.00n/a31
Jun ’23US$161.45
US$241.23
+49.4%
13.8%US$305.00US$181.00n/a30
May ’23US$198.76
US$272.07
+36.9%
9.9%US$340.00US$212.00n/a30
Apr ’23US$227.85
US$263.29
+15.6%
12.3%US$340.00US$196.00n/a31
Mar ’23US$197.64
US$273.13
+38.2%
13.9%US$350.00US$197.00n/a31
Feb ’23US$182.15
US$279.90
+53.7%
14.0%US$350.00US$197.00US$110.5031
Jan ’23US$204.75
US$290.72
+42.0%
11.9%US$350.00US$200.00US$105.2929
Dec ’22US$201.50
US$305.89
+51.8%
9.8%US$360.00US$200.00US$124.0728
Nov ’22US$269.17
US$307.23
+14.1%
8.8%US$340.00US$200.00US$160.5326
Oct ’22US$249.27
US$307.46
+23.3%
8.8%US$340.00US$200.00US$164.8126
Sep ’22US$269.97
US$307.46
+13.9%
8.8%US$340.00US$200.00US$172.9726
Aug ’22US$253.61
US$270.75
+6.8%
11.7%US$330.00US$175.00US$183.3024
Jul ’22US$251.16
US$260.96
+3.9%
11.3%US$330.00US$175.00US$179.2525
Jun ’22US$222.07
US$246.33
+10.9%
8.7%US$280.00US$175.00US$161.4524
May ’22US$208.51
US$249.65
+19.7%
9.2%US$280.00US$175.00US$198.7623
Apr ’22US$187.03
US$249.62
+33.5%
10.4%US$295.00US$175.00US$227.8521
Mar ’22US$223.40
US$232.00
+3.8%
16.2%US$295.00US$162.00US$197.6422
Feb ’22US$215.01
US$217.38
+1.1%
16.6%US$275.00US$161.00US$182.1521

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies